QTRX News
Archived Headlines
- Protein detection test company Quanterix sets terms for $50 million IPO 11/27/17
- US IPO Week Ahead: IPOs ready to launch in final stretch of 2017 11/24/17
- US IPO Weekly Recap: 10 companies go public in the busiest week of 2017 11/10/17
- Protein detection test company Quanterix files for a $58 million IPO 11/09/17
US IPO Week Ahead: 2018 IPO market kicks off with a quiet week
There are no deals set to price in the first week of the new year; however, filing activity will continue from companies targeting 1Q18 IPOs. The IPO market rounded out 2017 at an even 160 IPOs, raising $35.5 billion in total proceeds, nearly double that of 2016...read more
US IPO Weekly Recap: Year's largest biotech headlines 6-IPO week
Led by the largest biotech IPO since June 2015, six companies raised $827 million this past week. Biotech Denali Therapeutics raised $250 million, making it the largest biotech IPO of year by both deal size and market cap. The week also included pricings...read more
Protein detection test company Quanterix prices upsized IPO at $15 midpoint
Quanterix, which makes next-generation protein detection tests for clinical research, raised $64 million by offering 4.3 million shares at $15, within the range of $14 to $16. Quanterix plans to list on the Nasdaq under the symbol QTRX. J.P. Morgan, Leerink...read more
US IPO Week Ahead: Two big biotechs lead 6-IPO week
The 2017 IPO market's final two-week sprint kicks off this week with six IPOs targeting $731 million. The week's three health care IPOs each have significant insider buying, one of which could be the year's largest biotech IPO by market cap, ...read more